NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed May 31, 2012
Insider Transaction Report
Form 4
CHAMBON PHILIPPE
Director
Transactions
- Exercise/Conversion
Common Stock
2012-05-29$12.20/sh+2,442$29,792→ 1,149,378 total(indirect: See footnotes) - Exercise/Conversion
Stock Option (right to buy)
2012-05-29−2,442→ 0 totalExercise: $12.20From: 2007-05-30Exp: 2012-05-30→ Common Stock (2,442 underlying)
Footnotes (3)
- [F1]See Footnote 1 in Exhibit 99.1
- [F2]See Footnote 2 in Exhibit 99.1
- [F3]See Footnote 3 in Exhibit 99.1